- Frontier protein language model research
- Concentrates on drug discovery depth over broad coverage
- Scales to organization-wide healthcare rollouts
EvolutionaryScale
Frontier protein language model research
SF7.4
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Run virtual screens against targetsProtein modeling and research teams
Run virtual screens against targetsProtein modeling and research teams
Best for
Protein modeling and research teams
Pricing
Custom
SoftFinders Score
7.4 / 10
Overview
What is EvolutionaryScale?
EvolutionaryScale is an AI research company building large protein language models, including the ESM family, for biology and design. The product is positioned around R&D acceleration and computational biology rather than guaranteed clinical outcomes, and engagement typically happens through pharma partnerships rather than self-serve subscription buying. Buyers should weigh data access requirements, expected timelines to validated leads, and the cost structure across collaborations before committing to a long discovery program today.
The clearest fit for EvolutionaryScale is protein modeling and research teams, and the product leans into frontier protein language model research. One real limitation: research-facing rather than packaged product. Pricing is sales-led and scoped per buyer rather than posted publicly. Confirm validation depth, support coverage, and the rollout plan before signing.
KEY FEATURES
What you get out of the box
Protein Modeling
Predicts and designs protein structures
Knowledge Graph
Connects biological and chemical knowledge sources
Virtual Screening
Screens compound libraries against targets
Literature Intelligence
Mines biomedical literature for relevant evidence
Multi Omics
Integrates genomic and other omics data sources
Lab Integration
Connects discovery insights with wet-lab workflows
USE CASES
Where teams put it to work
Run virtual screens against targets
Collaborate with pharma partners
Bridge AI design and wet lab cycles
Identify drug targets from biology data
Accelerate molecule design cycles
Support protein engineering programs
Editorial Take
What we like, and what to verify
- Research-facing rather than packaged product
- Drug success still depends on downstream trials
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Iktos SF 7.4
Why consider it
Generative chemistry and synthesis planning AI
Cradle SF 7.5
Why consider it
AI protein design for wet labs
Chai Discovery SF 7.3
Why consider it
Molecular structure prediction for discovery research
NOETIK SF 7.1
Why consider it
Spatial biology models for cancer targets
Generate Biomedicines SF 7.7
Why consider it
Generative protein design across modalities
Causaly SF 7.6
Why consider it
Biomedical evidence and reasoning for R&D
FAQ